Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis. [electronic resource]
Producer: 20210108Description: 1849-1853 p. digitalISSN:- 1349-7235
- Aged
- Amino Acids, Branched-Chain -- adverse effects
- Anti-Bacterial Agents -- therapeutic use
- Blind Loop Syndrome -- chemically induced
- Breath Tests -- methods
- Hepatic Encephalopathy -- drug therapy
- Humans
- Lactulose -- adverse effects
- Liver Cirrhosis, Alcoholic -- complications
- Male
- Rifaximin -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.